DRNA - SEC Form 8-K filings

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Other Events, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits